Advertisement

Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 600x60px
Document › Details

MorphoSys AG. (3/9/16). "Press Release: MorphoSys to Present at Upcoming Investor Conferences".

Region Region Paris
  Country France
Organisations Organisation MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY)
  Group MorphoSys (Group)
  Organisation 2 Leerink Partners LLC
Products Product Oddo Biotech / Medtech Forum 2016 Paris
  Product 2 Kempen & Co Healthcare & Life Sciences Conference 2016 Amsterdam
Index terms Index term MorphoSys–Leerink: investor conference, 201603 supply service MorphoSys presents at Leerink Partners Annual Emerging Biotech Conference
  Index term 2 MorphoSys–Oddo: investor conference, 201603 supply service MorphoSys presents at Oddo Biotech/Medtech Forum in Paris
Persons Person Schottelius, Arndt (MorphoSys 200812–201701 Chief Developm Officer before Genentech LEFT 1/17)
  Person 2 Moroney, Simon E. (MorphoSys 1992– CEO + Founder)
     


MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY) will present at the following conferences:


Leerink Partners Annual Emerging Biotech Conference


Date: March 10, 2016

Venue: Snowbird, UT, USA

Presenter: Dr. Arndt Schottelius, Chief Development Officer of MorphoSys AG


Oddo Biotech / Medtech Forum


Date: March 31, 2016

Venue: Paris, France

Presenter: Dr. Simon Moroney, Chief Executive Officer of MorphoSys AG

Dr. Claudia Gutjahr-Löser, Head of Corporate Communications & IR


9th Kempen & Co Life Sciences Conference


Date: April 7, 2016

Venue: Amsterdam, the Netherlands

Presenter: Dr. Simon Moroney, Chief Executive Officer of MorphoSys AG

Dr. Claudia Gutjahr-Löser, Head of Corporate Communications & IR



A PDF version of all presentations will be provided at www.morphosys.com.



About MorphoSys:


MorphoSys developed HuCAL, the most successful antibody library technology in the pharmaceutical industry. By successfully applying this and other patented technologies, MorphoSys has become a leader in the field of therapeutic antibodies, one of the fastest-growing drug classes in human healthcare.


Together with its pharmaceutical partners, MorphoSys has built a therapeutic pipeline of more than 100 human antibody drug candidates for the treatment of cancer, rheumatoid arthritis, and Alzheimer's disease, to name just a few. With its ongoing commitment to new antibody technology and drug development, MorphoSys is focused on making the healthcare products of tomorrow. MorphoSys is listed on the Frankfurt Stock Exchange under the symbol MOR. For regular updates about MorphoSys, visit http://www.morphosys.com.

HuCAL®, HuCAL GOLD®, HuCAL PLATINUM®, CysDisplay®, RapMAT®, arYla®, Ylanthia®, 100 billion high potentials®, Slonomics®, Lanthio Pharma® and LanthioPep® are registered trademarks of the MorphoSys Group.



This communication contains certain forward-looking statements concerning the MorphoSys group of companies, The forward-looking statements contained herein represent the judgment of MorphoSys as of the date of this release and involve risks and uncertainties, Should actual conditions differ from the Company's assumptions, actual results and actions may differ from those anticipated, MorphoSys does not intend to update any of these forward-looking statements as far as the wording of the relevant press release is concerned
 


For more information, please contact:


MorphoSys AG


Dr. Claudia Gutjahr-Löser

Head of Corporate Communications & IR
Alexandra Goller

Senior Manager Corporate Communications & IR
Jochen Orlowski

Associate Director Corporate Communications & IR

Tel: +49 (0) 89 / 899 27-404

investors@morphosys.com

   
Record changed: 2017-07-02

Advertisement

Picture Fairtec GmbH We Optimise the ROI of Your Event 600x60px

More documents for MorphoSys (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px download




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px